Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Negro

Showing results (321-330 of 334) with videos related to

Pageof 34
Sort By:
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 7, 2019
Securing sustainable funding for viral hepatitis elimination plansAngelos Hatzakis, Jeffrey V Lazarus, Evangelos Cholongitas, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Antiviral Research|December 9, 2017
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countriesHakan Leblebicioglu, Joop E Arends, Resat Ozaras, et al.
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitisZobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisZobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2011
A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptWilliam Sievert, Ibrahim Altraif, Homie A Razavi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2011
A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelMarkus Cornberg, Homie A Razavi, Alfredo Alberti, et al.
Pageof 34

Showing results (321-330 of 334) with videos related to

Sort By:
Pageof 34
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 7, 2019
Securing sustainable funding for viral hepatitis elimination plansAngelos Hatzakis, Jeffrey V Lazarus, Evangelos Cholongitas, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Antiviral Research|December 9, 2017
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countriesHakan Leblebicioglu, Joop E Arends, Resat Ozaras, et al.
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitisZobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Hepatology (Baltimore, Md.)|December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisZobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2011
A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptWilliam Sievert, Ibrahim Altraif, Homie A Razavi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2011
A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelMarkus Cornberg, Homie A Razavi, Alfredo Alberti, et al.
Pageof 34